Instil Bio Stock Today
| TIL Stock | USD 8.55 0.41 4.58% |
PerformanceWeakest
| Odds Of DistressRisky
|
Instil Bio is selling for 8.55 as of the 26th of February 2026. This is a 4.58% down since the beginning of the trading day. The stock's lowest day price was 8.53. Instil Bio has a very high chance of experiencing financial distress in the next few years of operation. It has also generated negative returns for investors over the last 90 days. The performance scores are derived for the period starting the 28th of November 2025 and ending today, the 26th of February 2026. Click here to learn more.
Business Domain Pharmaceuticals, Biotechnology & Life Sciences | IPO Date 19th of March 2021 | Category Healthcare | Classification Health Care |
Instil Bio, Inc., a clinical-stage biopharmaceutical company, develops therapies for the treatment of patients with cancer. The company was incorporated in 2018 and is headquartered in Dallas, Texas. Instil Bio operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. The company has 6.78 M outstanding shares of which 462.75 K shares are at this time shorted by investors with about 1.84 days to cover. More on Instil Bio
Moving against Instil Stock
Follow Valuation Profit Patterns Odds of Bankruptcy
Check how we calculate scores
Instil Stock Highlights
ESG Sustainability
Environmental | Governance | Social |
| Old Names | [Till Capital Ltd, TIPTEL, Trilogy International Limited] | |||||||||||||||||||||||||||||||||||||||||||||
| Business Concentration | Biotechnology, Pharmaceuticals, Biotechnology & Life Sciences, Health Care, NASDAQ Composite, NASDAQ Composite Total, NASDAQ Health Care, Health Care, Biotechnology, Biotechnology, Healthcare (View all Sectors) | |||||||||||||||||||||||||||||||||||||||||||||
| Average Analyst Recommendation | ||||||||||||||||||||||||||||||||||||||||||||||
Financial Strength
| ||||||||||||||||||||||||||||||||||||||||||||||
Debt LevelsBy employing borrowed capital, Instil Bio can potentially magnify investment returns. Examining the debt-to-assets ratio offers investors perspective on Instil Bio's use of financial leverage and reveals what portion of Instil Bio's asset base relies on creditor financing.
| ||||||||||||||||||||||||||||||||||||||||||||||
Instil Bio (TIL) is traded on NASDAQ Exchange in USA and employs 14 people. Instil Bio is listed under Biotechnology category by Fama And French industry classification. The company currently falls under 'Micro-Cap' category with a total capitalization of 60.77 M. Instil Bio runs under Biotechnology sector within Health Care industry. The entity has 6.78 M outstanding shares of which 462.75 K shares are at this time shorted by investors with about 1.84 days to cover.
Instil Bio has about 354.61 M in cash with (55.7 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 2.73.
Check Instil Bio Probability Of Bankruptcy
Ownership AllocationThe market capitalization of Instil Bio is $60.77 Million. Over half of Instil Bio's outstanding shares are owned by outside corporations. These outside corporations are typically referred to as corporate investors that purchase positions in a given instrument to benefit from reduced trade commissions. Note, that even with negative profits, if the true value of the firm is larger than the current market value, you may still be able to generate positive returns on investment in this company.
Check Instil Ownership Details
Instil Stock Institutional Holders
| Instituion | Recorded On | Shares | |
| Boxer Capital Management, Llc | 2025-06-30 | 70.7 K | |
| Renaissance Technologies Corp | 2025-06-30 | 70.7 K | |
| Northern Trust Corp | 2025-06-30 | 64.4 K | |
| Assenagon Asset Management Sa | 2025-06-30 | 57.5 K | |
| Blackrock Inc | 2025-06-30 | 50.7 K | |
| Macquarie Group Ltd | 2025-06-30 | 50 K | |
| Geode Capital Management, Llc | 2025-06-30 | 43.1 K | |
| State Street Corp | 2025-06-30 | 17.6 K | |
| Trexquant Investment Lp | 2025-06-30 | 17.4 K | |
| Bml Capital Management Llc | 2025-06-30 | 534.9 K | |
| Cpmg Inc | 2025-06-30 | 410.9 K |
Instil Bio Historical Income Statement
Instil Stock Against Markets
Instil Bio Corporate Management
| Sandeep MD | CFO Officer | Profile | |
| Timothy Moore | Chief Officer | Profile | |
| Bronson Crouch | Chairman CEO | Profile | |
| Sumita JD | Compliance, Legal | Profile | |
| James MD | Chief Officer | Profile | |
| Mark Dudley | Chief Officer | Profile | |
| Robert MBBS | Head Development | Profile |
Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Instil Bio. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in gross domestic product. For more information on how to buy Instil Stock please use our How to buy in Instil Stock guide.You can also try the Balance Of Power module to check stock momentum by analyzing Balance Of Power indicator and other technical ratios.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Instil Bio. If investors know Instil will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. Comprehensive Instil Bio assessment requires weighing all these inputs, though not all factors influence outcomes equally.
Instil Bio's market price often diverges from its book value, the accounting figure shown on Instil's balance sheet. Smart investors calculate Instil Bio's intrinsic value - its true economic worth - which may differ significantly from both market price and book value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Since Instil Bio's trading price responds to investor sentiment, macroeconomic conditions, and market psychology, it can swing far from fundamental value.
Please note, there is a significant difference between Instil Bio's value and its price as these two are different measures arrived at by different means. Investors typically determine if Instil Bio is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Instil Bio's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.